leisure time -WSS

leisure time

author：comprehensive 2025-10-01 10:35:47 - browse：478

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 'Make People Better': The CRISPR babies story you probably don't know

focus

WSS

FDA drug safety: Singulair case shows systemic surveillance flaws

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

A new House health package & hospitals’ new site

The 10 drugs up first for Medicare price negotiation

Cybersecurity threat forces Lurie Children's to take systems offline

Do digital therapeutics have a future in medicine?

Wikipedia

leisure time

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Juul spent big to court Black leaders to promote its e

Wildfire smoke exposes gaps in outdoor worker protections

Why Novartis is changing the name of its research labs

ChatGPT in medicine: STAT answers readers' burning questions

Advances in CAR

Novavax promises a turnaround & Lilly roils the obesity market

Congressmen charge Covid hearing ‘could have been an email’

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

Vertex non

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Do digital therapeutics have a future in medicine?

Apple Vision Pro: A first look at health apps on the new VR headset

'Make People Better': The CRISPR babies story you probably don't know

Stem cell treatment guidelines are released by FDA

focus

focus

focus

entertainment